NLK通过调控paxillin促进膀胱癌细胞的增殖、迁移、侵袭及上皮间质转化

doi:10.3969/j.issn.1001-8131.2024.01.001

Abstract
Figure/Table
References
Related Citation (1)

Download: PDF (2119 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective This research was intended to exploring the effect and mechanism of kinase（NLK）and paxillin on proliferation,migration,invasion,and epithelial mesenchymal transition（EMT）of bladder cancer cells,and providing theoretical basis for basic research,clinical prevention and treatment of bladder cancer. Methods The expression of NLK in bladder cancer tissue was analyzed by bioinformatics analysis.The proliferation,migration and invasion of bladder cancer cells were detected by EdU staining assay,clone formation assay,and transwell assay.RNA pull down assay was used to detect the interaction between NLK and paxillin in bladder cancer cells.Western blot assay was used to detect the expressions of NLK,p-paxillin,and EMT-related proteins in bladder cancer cells. Results NLK and p-paxillin were highly expressed in bladder cancer;NLK interacted with paxillin;NLK downregulation inhibited the proliferation,migration,invasion,EMT,and p-paxillin expression of bladder cancer cells;paxillin overexpression reversed the effect of silencing NLK on proliferation,migration,invasion,EMT,and p-paxillin expression in bladder cancer cells. Conclusion NLK promoted the proliferation,migration,invasion and EMT of bladder cancer cells by regulating paxillin,providing theoretical basis for basic research,clinical prevention and treatment of bladder cancer.

Key words： Bladder cancer NLK paxillin EMT

Received: 20 December 2022

PACS:

R734.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Lu Jianjun
	Yu Qin
	Chen Lixiong

Cite this article:

Lu Jianjun,Yu Qin,Chen Lixiong. NLK Promotes the Proliferation,Migration,Invasion,and EMT of Bladder Cancer Cells by Regulating Paxillin[J]. journal1, 2024, 44(1): 1-7.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.01.001 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I1/1

[1] Saginala K,Barsouk A,Aluru JS,Rawla P,Padala SA,Barsouk A.Epidemiology of Bladder Cancer.Med Sci(Basel).2020;8(1).
[2] Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer [J] Clin.2018;68(6):394-424.
[3] Brott BK,Pinsky BA,Erikson RL.Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus.Proc Natl Acad Sci U S A.1998;95(3):963-8.
[4] Choi KW,Benzer S.Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene.Cell.1994;78(1):125-36.
[5] Lv M,Li Y,Tian X,et al.Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.Drug Des Devel Ther.2016;10:3737-46.
[6] Li M,Zhang S,Wang Z,et al.Prognostic significance of nemo-like kinase(NLK)expression in patients with gallbladder cancer.Tumour Biol.2013;34(6):3995-4000.
[7] Shen N,Duan XH,Wang XL,et al.Effect of NLK on the proliferation and invasion of laryngeal carcinoma cells by regulating CDCP1.Eur Rev Med Pharmacol Sci.2019;23(14):6226-33.
[8] Zhang W,He J,Du Y,et al.Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.World [J] Gastroenterol.2015;21(29):8836-47.
[9] Li SZ,Zeng F,Li J,et al.Nemo-like kinase(NLK)primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.Cancer Lett.2018;431:43-53.
[10] Zou D,Wang D,Li R,et al.MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK.Tumour Biol.2015;36(9):6725-32.
[11] Lei L,Wang Y,Zheng YW,et al.Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.Curr Cancer Drug Targets.2019;19(8):674-80.
[12] Ishitani T,Ishitani S,Matsumoto K,Itoh M.Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin.[J] Neurochem.2009;111(5):1104-18.
[13] Chiu HY,Sun KH,Chen SY,Wang HH,et al.Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.Cytokine.2012;59(2):423-32.
[14] 卫阳兵,闫鹏宇,杨晓峰.肿瘤微环境在膀胱癌发生发展中的作用机制.生命的化学. 2022;42(09):1665-71.
[15] Suwei D,Liang Z,Zhimin L,et al.NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.[J] Hematol Oncol.2015;8:120.
[16] Lamouille S,Xu J,Derynck R.Molecular mechanisms of epithelial-mesenchymal transition.Nat Rev Mol Cell Biol.2014;15(3):178-96.
[17] Zhang Y,Weinberg RA.Epithelial-to-mesenchymal transition in cancer:complexity and opportunities.Front Med.2018;12(4):361-73.
[18] Chi M,Liu J,Mei C,et al.TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.[J] Exp Clin Cancer Res.2022;41(1):175.
[19] Ma X,Hammes SR.Paxillin actions in the nucleus.Steroids.2018;133:87-92.
[20] Wen L,Zhang X,Zhang J,et al.Paxillin knockdown suppresses metastasis and epithelial mesenchymal transition in colorectal cancer via the ERK signalling pathway.Oncol Rep.2020;44(3):1105-15.
[21] Hou T,Zhou L,Wang L,et al.Leupaxin Promotes Bladder Cancer Proliferation,Metastasis,and Angiogenesis Thr-ough the PI3K/AKT Pathway.Cellular physiology and biochemistry:international journal of experimental ce-llular physiology,biochemistry,and pharmacology.2018;47(6):2250-60.
[22] Monami G,Gonzalez EM,Hellman M,et al.Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.Cancer research.2006;66(14):7103-10.